VRTX Financials

Vertex Pharmaceuticals Inc - Financial statements & key metrics

Stock Price

$480.25

Market Cap

$106.87B

P/E Ratio

29.7

Income Statement Highlights

Most Recent Quarter: FY

Revenue

$12.00B

Gross Profit

$10.35B

Operating Income

$4.17B

Net Income

$3.95B

EPS (Diluted)

$15.32

Balance Sheet Highlights

Total Assets

$25.64B

Total Liabilities

$6.98B

Shareholders Equity

$18.67B

Cash & Equivalents

$5.08B

Total Debt

Cash Flow Highlights

Operating Cash Flow

$3.63B

CapEx

$437.60M

Free Cash Flow

$4.07B

Profitability Metrics

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is VRTX revenue?

VRTX's most recent quarterly revenue was $12.00B. Annual revenue can be calculated by summing the four most recent quarters.

Is VRTX profitable?

VRTX reported a profit of $3.95B in the most recent quarter.

What is VRTX market cap?

VRTX has a market capitalization of $106.87B, making it a large-cap stock.

Does VRTX have debt?

View VRTX's balance sheet for debt information.

What is VRTX cash flow?

VRTX's most recent quarterly free cash flow was $4.07B.